Published in Biochem J on May 01, 2005
Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics (2008) 1.27
The pregnane X receptor: from bench to bedside. Expert Opin Drug Metab Toxicol (2008) 1.24
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists. Pharm Res (2009) 1.09
Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br J Pharmacol (2009) 1.07
Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells. BMC Cancer (2009) 1.02
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nat Rev Drug Discov (2015) 0.93
Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol (2011) 0.92
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Rev Drug Discov (2016) 0.92
The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury. Lab Invest (2009) 0.91
Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration. Mol Endocrinol (2011) 0.91
Nuclear receptors as drug targets in cholestatic liver diseases. Clin Liver Dis (2013) 0.91
Molecular Interactions between NAFLD and Xenobiotic Metabolism. Front Genet (2013) 0.88
The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol (2010) 0.88
Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics. Comp Hepatol (2009) 0.85
Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid. Am J Pathol (2010) 0.82
Focus on therapeutic strategies of nonalcoholic Fatty liver disease. Int J Hepatol (2012) 0.82
Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes. J Cell Sci (2011) 0.81
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatol Int (2008) 0.81
Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies. Toxicol Sci (2013) 0.80
Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver. Drug Metab Dispos (2013) 0.80
Predicting in vivo anti-hepatofibrotic drug efficacy based on in vitro high-content analysis. PLoS One (2011) 0.78
Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1'-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism. Toxicol Lett (2015) 0.78
Targeting the pregnane X receptor in liver injury. Expert Opin Ther Targets (2012) 0.76
Environmental xenoestrogens super-activate a variant murine ER beta in cholangiocytes. Toxicol Sci (2016) 0.76
MRP8/ABCC11 expression is regulated by dexamethasone in breast cancer cells and is associated to progesterone receptor status in breast tumors. Int J Breast Cancer (2011) 0.76
Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse. Toxicol Lett (2017) 0.75
Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation. PLoS One (2015) 0.75
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem (2000) 9.07
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol (1995) 7.12
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell (1998) 5.97
Liver regeneration. J Hepatol (2000) 5.22
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest (1998) 4.76
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A (2001) 4.58
Management of cirrhosis and ascites. N Engl J Med (2004) 4.31
Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol (2003) 4.25
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature (2000) 4.00
The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev (2003) 3.32
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem (2000) 3.23
Transcription factors in liver development, differentiation, and regeneration. Hepatology (2003) 3.06
Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis (2001) 2.98
Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem (2000) 2.58
Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology (1999) 2.30
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology (2001) 2.25
P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys (1999) 2.21
Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology (2000) 2.09
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos (2001) 1.70
Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology (2000) 1.67
Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci (2003) 1.42
Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J Biol Chem (1984) 1.37
Mesenchymal cells in the liver--one cell type or two? Liver (2002) 1.30
An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol (1993) 1.11
Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury. Gene Ther (1999) 1.05
Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology (1998) 1.02
PPAR alpha and the regulation of cell division and apoptosis. Toxicology (2002) 1.00
Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology (2004) 0.97
The role of inflammatory cells and cytochrome P450 in the potentiation of CCl4-induced liver injury by a single dose of retinol. Toxicol Appl Pharmacol (1996) 0.97
Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells. J Hepatol (2003) 0.94
Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line in vitro. Biochem J (2003) 0.91
Stem cell factor attenuates liver damage in a murine model of acetaminophen-induced hepatic injury. Lab Invest (2003) 0.91
Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid. Mol Pharmacol (1996) 0.85
Identification of a truncated ratp28-related protein expressed in kidney. Biochem Biophys Res Commun (2004) 0.84
Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model. Dig Dis Sci (2003) 0.84
Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein. Biochem Biophys Res Commun (1994) 0.83
Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2. Biochem Pharmacol (1997) 0.80
The cytochrome P450 3A4 inducer metyrapone is an activator of the human pregnane X receptor. Biochem Soc Trans (1999) 0.78
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab (2005) 9.14
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood (2006) 4.41
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev (2003) 3.74
The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev (2002) 2.95
Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol (2002) 2.94
Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem (2001) 2.70
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest (2003) 2.51
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32
Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol Cell Biol (2005) 2.32
Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem (2003) 2.28
Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol Cancer Ther (2004) 2.20
The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta (2005) 2.15
Liver fibrosis. Biochem J (2008) 1.97
Current and emerging concepts in tumour metastasis. J Pathol (2010) 1.88
Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol (2008) 1.85
The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol (2002) 1.78
Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology (2005) 1.73
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol (2006) 1.67
The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem (2004) 1.65
The inflammatory microenvironment in colorectal neoplasia. PLoS One (2011) 1.62
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol (2005) 1.53
Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nat Med (2011) 1.45
Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res (2004) 1.36
The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J Natl Cancer Inst (2011) 1.34
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol (2003) 1.31
The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor. Mol Endocrinol (2007) 1.29
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res (2004) 1.29
Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog (2013) 1.27
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res (2005) 1.25
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res (2005) 1.22
Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription. Mol Endocrinol (2004) 1.17
Profiling markers of prognosis in colorectal cancer. Clin Cancer Res (2006) 1.17
Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol (2002) 1.17
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J Pharmacol Exp Ther (2005) 1.16
Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem (2009) 1.14
Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. J Hepatol (2008) 1.13
Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J Pharmacol Exp Ther (2004) 1.11
cAMP-dependent axon guidance is distinctly regulated by Epac and protein kinase A. J Neurosci (2009) 1.10
Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett (2002) 1.10
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics (2002) 1.10
The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation. Hepatology (2010) 1.09
Diabetes area participation analysis: a review of companies and targets described in the 2008 - 2010 patent literature. Expert Opin Ther Pat (2010) 1.09
Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS One (2011) 1.08
Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. Int J Radiat Oncol Biol Phys (2004) 1.08
Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology (2006) 1.06
Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. J Lipid Res (2012) 1.05
Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response. Mol Cell Biol (2006) 1.04
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res (2012) 1.02
The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum Pathol (2010) 1.01
The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol (2004) 1.01
The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. PLoS One (2011) 1.00
Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer. J Clin Oncol (2006) 0.99
Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis. Proc Natl Acad Sci U S A (2007) 0.97
Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology (2004) 0.97
Glucocorticoid-dependent transdifferentiation of pancreatic progenitor cells into hepatocytes is dependent on transient suppression of WNT signalling. J Cell Sci (2010) 0.97
Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncol (2005) 0.97
Transgenic mouse models of human CYP3A4 gene regulation. Mol Pharmacol (2003) 0.95
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling. BMC Cancer (2009) 0.94
Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun (2012) 0.93
Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics. J Hepatol (2005) 0.93
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology (2009) 0.92
Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line in vitro. Biochem J (2003) 0.91
Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Hum Pathol (2002) 0.90
Exocrine pancreas trans-differentiation to hepatocytes--a physiological response to elevated glucocorticoid in vivo. J Steroid Biochem Mol Biol (2009) 0.90
AR42J-B-13 cell: an expandable progenitor to generate an unlimited supply of functional hepatocytes. Toxicology (2010) 0.90
The use of formalin fixed wax embedded tissue for proteomic analysis. J Clin Pathol (2011) 0.89
Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Histopathology (2013) 0.88
CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. Oncol Rep (2002) 0.88
The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol (2010) 0.88
Single-channel characterization of the rabbit recombinant RyR2 reveals a novel inactivation property of physiological concentrations of ATP. J Membr Biol (2008) 0.88
Metabolites of progesterone and the pregnane X receptor: a novel pathway regulating uterine contractility in pregnancy? Am J Obstet Gynecol (2005) 0.87
A role for the pregnane X receptor in flucloxacillin-induced liver injury. Hepatology (2010) 0.87
Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity. Cell Microbiol (2014) 0.86
Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. Saudi Med J (2004) 0.85
Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics. Comp Hepatol (2009) 0.85
Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes. Cancer Chemother Pharmacol (2004) 0.84
Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation. Gut (2013) 0.84
Biomarkers of colorectal cancer: recent advances and future challenges. Proteomics Clin Appl (2015) 0.84
Laser capture microdissection and PCR for analysis of human papilloma virus infection. Methods Mol Biol (2005) 0.84
Identification of a truncated ratp28-related protein expressed in kidney. Biochem Biophys Res Commun (2004) 0.84
Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study. BMC Res Notes (2012) 0.83
Nuclear receptor regulation of genes involved in bile acid metabolism. Crit Rev Eukaryot Gene Expr (2002) 0.83
Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis. Oncol Rep (2002) 0.83
Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer. J Pathol (2012) 0.83
Isolated tuberculosis of the liver: a diagnostic challenge. BMJ Case Rep (2011) 0.83
Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient. Clin Genitourin Cancer (2007) 0.83
Progress in the identification of plasma biomarkers of colorectal cancer. Proteomics (2013) 0.83
Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid. Am J Pathol (2010) 0.82
Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res (2007) 0.81
Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes. J Cell Sci (2011) 0.81
Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signalling pathway. Biochem Pharmacol (2003) 0.81
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatol Int (2008) 0.81
Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies. Toxicol Sci (2013) 0.80
Expression of CYP2S1 in human hepatic stellate cells. FEBS Lett (2007) 0.80
The proteomics of formalin-fixed wax-embedded tissue. Clin Biochem (2012) 0.80